logo

Perrigo Co. (PRGO)



Trade PRGO now with
  Date
  Headline
11/8/2018 6:05:50 AM Perrigo Co. Q3 Net Loss $68 Mln Or $0.49/shr Vs. Net Income $45 Mln Or $0.31/shr Last Year
10/31/2018 11:46:37 AM Perrigo Co. (PRGO) Declares Quarterly Dividend of $ 0.19, Record Date 11/30/2018
10/31/2018 11:33:47 AM Perrigo Declares Quarterly Dividend Of $0.19, Payable Dec. 18/ Record Nov. 30
10/29/2018 9:12:04 AM Perrigo Confirms Patent Challenge For Generic Version Of Kerydin
10/26/2018 9:25:09 AM Perrigo Confirms Patent Challenge For Generic Version Of Narcan
10/15/2018 8:59:53 AM Perrigo Announces Launch Of AB Rated Generic Version Of Androgel Topical Gel, 1.62%
10/8/2018 5:45:13 PM Perrigo Appoints Murray Kessler As President And CEO
10/1/2018 10:27:54 AM Perrigo Confirms Patent Challenge For Generic Version Of Jublia Topical Solution 10%
9/28/2018 9:03:03 AM Perrigo Announces Patent Litigation Settlement For The Generic Version Of Picato Gel; Terms Of Settlement Undisclosed
9/7/2018 9:06:15 AM Perrigo Announces FDA Approval And Planned Launch For Store Brand OTC Equivalent Of Imodium Multi-Symptom Relief